Hey there, fellow cancer warriors! Let’s talk about iTeos Reports Second Quarter 2022 Financial Results and Business Update So, iTeos has been bustling with activity lately, enrolling patients left and right in their Phase 2 trial expansions. One of the exciting developments is the evaluation of anti-TIGIT monoclonal antibody, EOS-448/GSK4428859A, in combination with GSK’s anti-PD-1…
Zahid F. Sarder Saddi and US House Representatives Celebrate “Little Bangladesh” in NYC Embracing Diversity in Brooklyn, New York It was a momentous occasion for the Bangladeshi community in Brooklyn, New York, as Zahid F. Sarder Saddi, a dedicated civil society leader and community activist, joined hands with US House Representatives Meeks, Jeffries, Clark, and…
Tech Companies Fuel Massive Data Center Construction Boom New York, US, Aug. 03, 2022 (GLOBE NEWSWIRE) — According to a comprehensive research report by Market Research Future (MRFR), the Data Center Construction Market is set to reach new heights. The Influence of Tech Companies Tech giants such as Google, Amazon, and Microsoft are driving the…
Promaxo Announces Research Collaborations with Leading European Universities Oakland, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) — Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced it has entered into research collaborations with leading European university hospitals, Imperial College London and University Hospital Tuebingen Germany, for MR guided prostate…
Embracing Change: The Impact of Vantage Drilling International’s Earnings Release A New Chapter As we approach the second quarter of 2022, Vantage Drilling International has set the stage for a pivotal moment in its journey. The Company’s decision to host a conference call to discuss its operating results demonstrates a commitment to transparency and accountability….
Welcome to the MediciNova Phase 2 Trial Blog! Celebrating New Breakthroughs in Medical Research July 26, 2022 Hey there, readers! Have you heard the latest news from MediciNova, Inc.? They just announced the initiation of a Phase 2 clinical trial to evaluate MN-001 (tipelukast) for the treatment of patients with non-alcoholic fatty liver disease (NAFLD)…
The Conference Returns as A Live In-person Event SAN JOSE, Calif., July 25, 2022 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest storage and memory test solutions at Flash Memory Summit 2022, the largest conference featuring memory and its storage applications, on August 2-4. After a long…
Upcoming Investor Deadline for IonQ, Inc. Securities Are You Eligible to Seek Appointment as Lead Plaintiff? SAN DIEGO, July 22, 2022 (GLOBE NEWSWIRE) – Robbins Geller Rudman & Dowd LLP Announces that purchasers or acquirers of IonQ, Inc. (NYSE: IONQ; IONQ/WS) securities between March 30, 2021 and May 2, 2022, inclusive (the “Class Period”) have…
